CE > Interventional Cardiology
Significance of Restenosis in PCI
Program Overview:
A primary complication of percutaneous coronary intervention (PCI) is restenosis. This course provides an overview of the history of treating coronary artery disease and restenosis. This course also covers how vessels respond to injury from Plain Old Balloon Angioplasty (POBA) and stent implantation. Finally, the prevalence, risk factors and significance of restenosis are reviewed, as well as therapeutic options for treating restenosis.
Program Objectives:
Upon completion of this program, the participant should be able to:
- Outline the history of coronary artery disease treatment and restenosis
- Define restenosis using clinical research terminology
- Describe how vessels respond to injury from Plain Old Balloon Angioplasty (POBA) and stent implantation
- Describe the prevalence, risk factors, and significance of restenosis
- Identify therapeutic options for treating restenosis
Intended Audience:
This program is intended for registered nurses and radiologic technologists.
Program Location/Availability:
Program is presented in-person and held on-site at the hospital.
CE programs are subject to change. Courses are held on site unless otherwise indicated by your local Boston Scientific Representative.
Continuing Education:
- Nurses: 1 contact hour is awarded for this program
Boston Scientific Corporation is an approved provider of continuing nursing education by the Wisconsin Nurses Association Continuing Education Approval Program Committee, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation
Provider approved by the California Board of Nursing, provider number CEP12818
- Technologists: Program approved for 1 Category A Credit by the American Society of Radiologic Technologists (ASRT)
Requirements for Successful Completion
Attendees are required to sign-in on the attendance sheet. Obtaining full credit for this program depends upon attendance from beginning to end. The presenter will monitor the program for attendance for the entire program, and attendees should only claim credit commensurate with the extent of their attendance. Participants are requested to complete the pre- and post-evaluations for the program.
Disclosures
- Commercial Support: This program was developed by Boston Scientific Corporation
- Planning Committee: The planning committee members who participated in the development of this program are employees of Boston Scientific Corporation. For additional information, contact the CE program representative at (763) 494-1627 or via email at BostonScientific-CE@bsci.com
- Faculty: This program is presented by an employee of Boston Scientific Corporation. The employee presenter is not a physician or healthcare provider. These materials are intended to reflect generally accepted medical principles and standards of care
- Non-endorsement of Products: Approval of Boston Scientific Corporation as an approved provider of continuing nursing education does not imply endorsement by the WNA CEAP or ANCC of any commercial products displayed in conjunction with an activity
- No Off-Label Use: The information contained in these materials is limited to information about products and product uses that have been approved or cleared by the U.S. Food and Drug Administration (FDA)
Questions
If you have any questions regarding any of these programs, contact your local Boston Scientific Representative. You may also contact the CE Program Representative at (763) 494-1627 or via email at BostonScientific-CE@bsci.com.
